Clinical trial
Influence of Systemic Propranolol Treatment on the Physical Development of Paediatric Patients With Infantile Hemangiomas
NCT04651049 is registered in ClinicalTrials.gov with Qilu Hospital of Shandong University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Influence of Systemic Propranolol Treatment on the Physical Development of Paediatric Patients With Infantile Hemangiomas
- Lead sponsor
- Qilu Hospital of Shandong University
- Phase
- Observational
- Overall status
- Completed
- Start date
- July 15, 2010
- Completion date
- February 10, 2020
- Enrollment
- 128 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
infantile haemangiomas